Patents Assigned to STB, Ltd
  • Publication number: 20170007742
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings, particularly for the treatment of injured tissue via endoscopic or minimally-invasive surgical techniques.
    Type: Application
    Filed: September 20, 2016
    Publication date: January 12, 2017
    Applicant: STB, Ltd.
    Inventors: Martin MACPHEE, Belinda WILMER, Dawson BEALL, Jennifer Brichetti
  • Publication number: 20170000922
    Abstract: Disclosed are solid and frozen haemostatic materials and dressing's consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
    Type: Application
    Filed: September 19, 2016
    Publication date: January 5, 2017
    Applicant: STB, Ltd.
    Inventors: Martin MACPHEE, Jerry KANELLOS, Belinda WILMER, Dawson BEALL
  • Publication number: 20160317700
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings.
    Type: Application
    Filed: July 12, 2016
    Publication date: November 3, 2016
    Applicant: STB, Ltd.
    Inventors: Martin MACPHEE, Dawson BEALL
  • Publication number: 20160317355
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of fibrinogen and a fibrinogen activator, wherein the fibrinogen is present in an amount between 3.0 mg/cm2 of the wound facing surface of the dressing and 13.0 mg/cm2 of the wound facing surface of the dressing. Also disclosed are methods for treating wounded tissue.
    Type: Application
    Filed: July 12, 2016
    Publication date: November 3, 2016
    Applicant: STB, Ltd.
    Inventors: Martin MACPHEE, Dawson BEALL
  • Publication number: 20160121016
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
    Type: Application
    Filed: January 8, 2016
    Publication date: May 5, 2016
    Applicant: STB, Ltd.
    Inventors: Martin MACPHEE, Jerry KANELLOS, Belinda WILMER, Dawson BEALL
  • Patent number: 9259503
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
    Type: Grant
    Filed: August 18, 2015
    Date of Patent: February 16, 2016
    Assignee: STB, LTD.
    Inventors: Martin MacPhee, Jerry Kanellos, Belinda Wilmer, Dawson Beall
  • Publication number: 20150352245
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
    Type: Application
    Filed: August 18, 2015
    Publication date: December 10, 2015
    Applicant: STB, LTD.
    Inventors: Martin MACPHEE, Jerry KANELLOS, Belinda WILMER, Dawson BEALL
  • Publication number: 20150283288
    Abstract: Disclosed are solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator, wherein the haemostatic layer(s) is cast or formed from a single aqueous solution containing the fibrinogen component and the fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen compositions useful for preparing the haemostatic layer(s) of these dressings.
    Type: Application
    Filed: June 22, 2015
    Publication date: October 8, 2015
    Applicant: STB, LTD.
    Inventors: Martin MACPHEE, Dawson BEALL
  • Patent number: 9131929
    Abstract: Disclosed are solid and frozen haemostatic materials and dressings consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods of treating internal wounded tissue in a mammal by applying one or more of these haemostatic materials and dressings.
    Type: Grant
    Filed: April 5, 2011
    Date of Patent: September 15, 2015
    Assignee: STB, Ltd.
    Inventors: Martin MacPhee, Jerry Kanellos, Belinda Wilmer, Dawson Beall
  • Patent number: 8445009
    Abstract: Disclosed are processes for preparing solid dressings for treated wounded tissue in mammalian patients, such as a human, comprising a haemostatic layer consisting essentially of a fibrinogen component and a fibrinogen activator. Also disclosed are methods for treating wounded tissue using these dressings and frozen and liquid compositions useful for preparing the haemostatic layer(s) of these dressings or for treating wounded tissue in a mammal.
    Type: Grant
    Filed: August 6, 2007
    Date of Patent: May 21, 2013
    Assignee: STB, Ltd
    Inventors: Martin MacPhee, Dawson Beall